Register for the Beta

ADHD Is Highly Heritable — So Why Can Identical Twins Still Differ?

Brain, Mood & Behavior Article 10 of 11

High heritability does not mean genetic certainty. Twin studies show strong inherited influence alongside within-pair differences, development, measurement effects and nonshared experience.

Authors
Thomas Byman & Tobias Byman TwinPare Research
Category
Research / Brain, Mood & Behavior
Language
English
Status
Published
Source status
Sources reviewed for publication
Last reviewed
2026-09-30
Reading time
9 min read
Two genetically similar people showing different attention and activity patterns, illustrating why high heritability does not make ADHD symptoms identical.

ADHD is often described as highly heritable. That phrase is scientifically meaningful — and also easy to misunderstand.

If heritability is high, it can sound as though identical twins should have identical symptoms or that an individual diagnosis is mostly “written in the genes”. Twin research does not support either conclusion. Heritability describes why people differ within a studied population under particular conditions; it does not assign a genetic percentage to one person.

Identical twins can differ in ADHD-related traits, and genetically informed research shows why the more accurate story is about inherited susceptibility interacting with development, individual-specific experience, measurement and biological variation.

Quick answer

If ADHD is highly heritable, why can identical twins still differ?

Because heritability is not genetic determinism. Identical twins share nearly all inherited DNA, yet development still includes nonshared experiences, biological and stochastic variation, measurement differences and potentially differences in environmental sensitivity. Those factors can contribute to within-pair differences without making ADHD “non-genetic”.

Key takeaways

  • A 2023 Swedish study of tens of thousands of twin pairs found substantial genetic influence on both clinically registered ADHD and ADHD traits, with the relative genetic/environmental contribution broadly stable across birth cohorts despite changing prevalence.
  • A nationwide study of 59,514 Swedish twins estimated high heritability for clinically defined ADHD, including substantial heritability in adults — but the estimate depends on how ADHD is defined and ascertained.
  • Selected identical-twin pairs can be discordant for attention problems and ADHD. Developmental and environmental markers can differ within pairs, but those associations alone do not identify a cause.
  • A children-of-twins-and-siblings study found that parent-child resemblance in ADHD behaviors was largely explained by genetic transmission in that design; that finding does not make parenting or family environment irrelevant to functioning and outcomes.
  • A 2025 genome-wide study of monozygotic twin differences examined genetic influences on environmental sensitivity, but ADHD-specific estimates were imprecise and not statistically significant — a useful reason to avoid deterministic gene-by-environment claims.

What “highly heritable” actually means

Heritability is a population-level estimate of how much variation in a measured trait is statistically associated with genetic differences under the conditions of that study. It does not say what fraction of one person’s ADHD is genetic, and it does not tell us whether a symptom can change.

The number can also change when researchers change the phenotype, informant, age range or clinical definition. That is why estimates from parent-rated childhood traits, adult self-report and register-defined diagnosis should not be treated as if they measured exactly the same thing.

The Swedish time-trend study: strong genetic influence did not disappear as diagnoses increased

A 2023 study linked Swedish twin-registry data with clinical registers and also used parent-rated ADHD traits from CATSS. It included 22,678 twin pairs from the Swedish Twin Registry and 15,036 CATSS pairs born across multiple cohorts.

For register-defined ADHD, heritability estimates ranged from 66% to 86% across time, but those fluctuations were not statistically significant. For ADHD traits, heritability was estimated at about 64–65%. The authors concluded that the relative genetic and environmental contribution remained broadly stable despite the rise in ADHD prevalence.

That result does not explain the prevalence increase away. It does not prove that detection is the only reason diagnoses rose, and it does not mean every individual case has the same genetic architecture.

Clinical diagnosis produces a different estimate than some symptom scales

In a nationwide Swedish study of 59,514 twins, clinically defined ADHD based on patient-register diagnoses and prescribed ADHD medication showed an overall heritability estimate of 0.88, with an adult estimate of 0.72.

Those figures are useful evidence that clinically ascertained ADHD can show strong genetic influence across the lifespan. They are not universal constants. Different raters, symptom scales, diagnostic rules and ascertainment methods can produce different estimates.

Identical twins can still be discordant

A 2007 study selected monozygotic twin pairs who were concordant or discordant for attention problems and ADHD-related outcomes. Affected co-twins in discordant pairs differed from their unaffected co-twins on multiple measures, and behavioral discordance was visible from early childhood.

The study also reported differences in developmental and environmental markers such as birth weight, growth and some family or exposure variables. But a marker that differs within a pair is not automatically a proven cause. Selection, measurement, reverse causation and unmeasured familial or developmental processes can still matter.

Why environmental headlines need genetically informed designs

Environmental exposures are often associated with ADHD in observational studies. A 2024 methodological commentary emphasized that even large meta-analyses can remain confounded by familial and genetic factors when those factors were not measured or controlled.

The right conclusion is not that environment is irrelevant. It is that causal claims require designs capable of separating exposure from inherited and family-level confounding. Twin, sibling, adoption, within-family genomic and other genetically informed approaches can help, but each has its own assumptions.

Parent-child resemblance is not the same as a parenting effect

A 2024 children-of-twins-and-siblings study included 22,276 parents and 11,566 children. In that design, resemblance between parental and child ADHD behaviors was largely explained by genetic transmission, while estimated environmental transmission from parental ADHD behaviors was small.

This does not justify the statement “parenting does not matter”. The study addressed one specific pathway: whether parental ADHD behaviors themselves explained the intergenerational resemblance in child ADHD behaviors. Family support, structure, stress, schooling, relationships and access to care can still affect functioning and outcomes.

The 2025 monozygotic-twin genetics study adds a different question

A large Nature Human Behaviour study combined up to 21,792 monozygotic twins from 11 studies to investigate genetic influences on environmental sensitivity across seven psychiatric and neurodevelopmental phenotypes, including ADHD symptoms.

For ADHD, the SNP-heritability estimates for environmental sensitivity were imprecise and not statistically significant. That means the study should not be used to claim that researchers have found a reliable genetic switch controlling how strongly a person’s ADHD responds to the environment.

Its value is conceptual: even when twins share inherited DNA, phenotypic differences can be studied as outcomes in their own right, and gene–environment interplay may be more complicated than a simple “genes versus environment” split.

Why two genetically identical people can still have different symptom profiles

ADHD is developmentally expressed. Attention, activity and impulsivity are measured across changing school, work and social demands, and different informants can observe different parts of a person’s behavior. Symptom profiles can also change with age.

Nonshared experiences, medical and developmental events, stochastic biological processes, epigenetic differences and measurement variation can all contribute to within-pair differences. Twin research cannot assign one of these explanations to an individual pair without direct evidence.

The TwinPare boundary

TwinPare Research can explain population-level heritability, discordant-twin logic and why genetically informed designs improve causal reasoning. It can help users understand why a high heritability estimate and individual change are not contradictory.

TwinPare Health & Fitness should not diagnose ADHD, infer ADHD from activity, sleep, HRV or behavioral data, calculate a personal genetic ADHD percentage, or advise a user to start, stop or change medication. Concerns about attention, impulsivity or functioning require appropriate professional assessment.

Source notes

The sources have been verified and editorially reviewed for this article. The limitations below show which level of conclusion the sources support.

  1. [taylor-adhd-over-time-2023] A twin study of genetic and environmental contributions to attention-deficit/hyperactivity disorder over time Mark J. Taylor; Joanna Martin; Agnieszka Butwicka; Paul Lichtenstein; Brian D’Onofrio; Sebastian Lundström; Henrik Larsson; Mina A. Rosenqvist. Journal of Child Psychology and Psychiatry, 2023. Evidence type: Swedish population twin study using 22,678 twin pairs from the Swedish Twin Registry and 15,036 CATSS pairs to examine ADHD diagnoses, medication and traits across birth cohorts Limitation: Register-defined ADHD heritability ranged from 66% to 86% across time and ADHD-trait heritability was about 64–65%; fluctuations in register heritability were not statistically significant. The study does not show that prevalence changes are fully explained or that an individual ADHD presentation is a fixed genetic percentage. PubMed DOI
  2. [larsson-clinical-adhd-2014] The heritability of clinically diagnosed attention deficit hyperactivity disorder across the lifespan Henrik Larsson; Zheng Chang; Brian M. D’Onofrio; Paul Lichtenstein. Psychological Medicine, 2014. Evidence type: Nationwide Swedish Twin Registry study of 59,514 twins using clinical register diagnoses and ADHD medication records Limitation: The best-fitting model estimated high heritability for clinically defined ADHD overall and substantial heritability in adults. Estimates depend on phenotype and ascertainment and must not be translated into a personal genetic percentage or diagnostic certainty. PubMed PMC DOI
  3. [lehn-discordant-mz-adhd-2007] Attention problems and attention-deficit/hyperactivity disorder in discordant and concordant monozygotic twins: evidence of environmental mediators Hanne Lehn; Eske M. Derks; James J. Hudziak; Peter Heutink; Toos C. E. M. van Beijsterveldt; Dorret I. Boomsma. Journal of the American Academy of Child & Adolescent Psychiatry, 2007. Evidence type: Selected longitudinal monozygotic twin study of 95 pairs enriched for concordant or discordant attention problems and ADHD Limitation: Within-pair differences were visible early and several developmental/environmental markers differed between affected and unaffected co-twins. These associations do not establish that birth weight, maternal smoking or another measured factor caused ADHD. PubMed DOI
  4. [kleppesto-intergenerational-adhd-2024] Intergenerational transmission of ADHD behaviors: genetic and environmental pathways Thomas H. Kleppesto; Espen Moen Eilertsen; Elsje van Bergen; Hans Fredrik Sunde; Brendan Zietsch; Magnus Nordmo; Nikolai Haahjem Eftedal; Alexandra Havdahl; Eivind Ystrom; Fartein Ask Torvik. Psychological Medicine, 2024. Evidence type: Children-of-twins-and-siblings study with 22,276 parents and 11,566 eight-year-old children Limitation: Parent-child resemblance in ADHD behaviors was largely explained by genetic transmission in this design, with small environmental-transmission estimates. This does not imply that parenting, family support or environment are irrelevant to functioning, wellbeing or outcomes. PubMed DOI
  5. [faraone-environmental-adhd-2024] Understanding Environmental Exposures and ADHD: a Pathway Forward Stephen V. Faraone. Prevention Science, 2024. Evidence type: Commentary synthesising environmental-exposure meta-analyses and emphasizing unresolved familial and genetic confounding Limitation: Environmental associations can remain confounded by familial or genetic factors even when exposure precedes ADHD measurement. The source supports cautious causal interpretation rather than dismissing environmental influence. PubMed DOI
  6. [assary-mz-environmental-sensitivity-2025] Genetics of monozygotic twins reveals the impact of environmental sensitivity on psychiatric and neurodevelopmental phenotypes Elham Assary et al.. Nature Human Behaviour, 2025. Evidence type: Genome-wide meta-analysis of monozygotic twin differences using up to 21,792 MZ twins (10,896 pairs) from 11 studies across seven psychiatric and neurodevelopmental phenotypes Limitation: The study included ADHD symptoms and investigated genetic contributions to environmental sensitivity. ADHD environmental-sensitivity SNP-heritability estimates were imprecise and not statistically significant. It supports a more complex gene-environment framework, not a deterministic modifier claim. PubMed DOI
Editorial source review

This section shows how the article's key factual claims are linked to the source.

Phrasings that require caution

  • Do not write that an individual person’s ADHD is a fixed percentage genetic.
  • Do not equate high heritability with inevitability, permanence or diagnostic certainty.
  • Do not imply identical twins must be symptom-identical.
  • Do not treat ADHD traits, screening classifications and clinically registered diagnoses as interchangeable phenotypes.
  • Do not infer that a discordant-twin environmental marker caused ADHD without stronger causal evidence.
  • Do not state that increasing diagnosis prevalence is fully explained by detection or that the underlying biology has changed.
  • Do not write that parenting does not matter.
  • Do not interpret the 2025 MZ-difference GWAS as proving a specific ADHD gene-by-environment mechanism; the ADHD sensitivity estimates were imprecise and not statistically significant.
  • Do not encourage self-diagnosis or medication decisions from twin/family resemblance or wearable data.
IDClaimSource supportCaution